At Velakor Biotherapeutics, we’re pioneering a therapy that harnesses the body’s natural ability to repair heart tissue after a heart attack or heart failure. Our innovative approach to rejuvenating the extracellular matrix (ECM) has been shown to protect and regenerate heart tissue in animal models.
Velakor is developing cardiac therapies to promote a future where heart disease patients live healthier, longer lives. We aspire to utilize innovative approaches to discover new therapies that support cardiac regeneration and repair.